The latest federal investment brings ibogaine—yes, the Schedule I substance—one step closer to U.S. clinical trials, months after Trump signed an executive ...

The brain has a remarkable ability to recognize danger, but new research suggests that this survival mechanism may also explain why people sometimes feel ...

We’ve all had nightmares at some point. The agitation, the fear, the scenarios our own minds create and take us into. The problem is that for people with ...

This week’s newsletter covers groundbreaking research on ayahuasca’s effects on PTSD-related brain circuits, CBD’s potential for traumatic brain ...

vote happening now